NYSE:AGL Agilon Health (AGL) Stock Price, News & Analysis $2.12 -0.07 (-2.98%) Closing price 06/20/2025 03:59 PM EasternExtended Trading$2.12 +0.01 (+0.28%) As of 06/20/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Agilon Health Stock (NYSE:AGL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Agilon Health alerts:Sign Up Key Stats Today's Range$2.10▼$2.2350-Day Range$2.10▼$5.6052-Week Range$1.50▼$7.73Volume3.12 million shsAverage Volume4.98 million shsMarket Capitalization$875.50 millionP/E RatioN/ADividend YieldN/APrice Target$4.79Consensus RatingHold Company Overviewagilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.Read More… Agilon Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks66th Percentile Overall ScoreAGL MarketRank™: Agilon Health scored higher than 66% of companies evaluated by MarketBeat, and ranked 314th out of 924 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.1 / 5Analyst RatingHold Consensus RatingAgilon Health has received a consensus rating of Hold. The company's average rating score is 2.17, and is based on 5 buy ratings, 11 hold ratings, and 2 sell ratings.Amount of Analyst CoverageAgilon Health has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Agilon Health's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Agilon Health are expected to grow in the coming year, from ($0.59) to ($0.40) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Agilon Health is -3.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Agilon Health is -3.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAgilon Health has a P/B Ratio of 1.86. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Agilon Health's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted6.64% of the float of Agilon Health has been sold short.Short Interest Ratio / Days to CoverAgilon Health has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Agilon Health has recently decreased by 9.59%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAgilon Health does not currently pay a dividend.Dividend GrowthAgilon Health does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted6.64% of the float of Agilon Health has been sold short.Short Interest Ratio / Days to CoverAgilon Health has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Agilon Health has recently decreased by 9.59%, indicating that investor sentiment is improving significantly. News and Social Media3.8 / 5News Sentiment0.87 News SentimentAgilon Health has a news sentiment score of 0.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.67 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Agilon Health this week, compared to 5 articles on an average week.Search Interest2 people have searched for AGL on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows1 people have added Agilon Health to their MarketBeat watchlist in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Agilon Health insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.57% of the stock of Agilon Health is held by insiders.Read more about Agilon Health's insider trading history. Receive AGL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Agilon Health and its competitors with MarketBeat's FREE daily newsletter. Email Address AGL Stock News HeadlinesAgilon Health, Inc. (NYSE:AGL) Receives Average Recommendation of "Hold" from AnalystsJune 18, 2025 | americanbankingnews.comAgilon Health Sees Unusually Large Options Volume (NYSE:AGL)June 18, 2025 | americanbankingnews.comTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada the 51st state because he’s desperate for critical minerals… They think his involvement in Ukraine is just another resource grab… They think his tariffs will wreck the economy… But they’re all missing the bigger picture.June 22, 2025 | Porter & Company (Ad)New Research Underscores the Important Role of Value-Based Care (VBC) in Improving Primary Care ...June 9, 2025 | gurufocus.comNew Research Underscores the Important Role of Value-Based Care (VBC) in Improving Primary Care Access for Traditional Medicare PatientsJune 9, 2025 | businesswire.comAgilon Health’s SWOT analysis: stock faces headwinds amid profitability pushMay 28, 2025 | uk.investing.comagilon health to Participate in Bernstein's 41st Annual Strategic Decisions ConferenceMay 19, 2025 | gurufocus.comagilon health to Participate in Bernstein's 41st Annual Strategic Decisions ConferenceMay 19, 2025 | businesswire.comSee More Headlines AGL Stock Analysis - Frequently Asked Questions How have AGL shares performed this year? Agilon Health's stock was trading at $1.90 at the beginning of the year. Since then, AGL stock has increased by 11.3% and is now trading at $2.1150. View the best growth stocks for 2025 here. How were Agilon Health's earnings last quarter? Agilon Health, Inc. (NYSE:AGL) posted its quarterly earnings data on Tuesday, May, 6th. The company reported $0.03 earnings per share for the quarter, beating analysts' consensus estimates of ($0.01) by $0.04. The firm's revenue for the quarter was down 4.5% on a year-over-year basis. Read the conference call transcript. When did Agilon Health IPO? Agilon Health (AGL) raised $1 billion in an initial public offering on Thursday, April 15th 2021. The company issued 46,600,000 shares at $20.00-$23.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Deutsche Bank Securities and Wells Fargo Securities served as the underwriters for the IPO and William Blair, Truist Securities and Nomura were co-managers. Who are Agilon Health's major shareholders? Top institutional shareholders of Agilon Health include Vanguard Group Inc. (7.33%), Wellington Management Group LLP (3.62%), Goldman Sachs Group Inc. (1.22%) and Charles Schwab Investment Management Inc. (1.20%). Insiders that own company stock include Cd&R Investment Associates Ix,, Veeral Desai, John William Wulf, Benjamin Shaker, Karen Mcloughlin, Steven Sell, Diana Mckenzie, Benjamin Kornitzer, Jeffrey A Schwaneke and Timothy Gertsch. View institutional ownership trends. How do I buy shares of Agilon Health? Shares of AGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Agilon Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Agilon Health investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), The RMR Group (RMR), AU Optronics (AUOTY), DiamondRock Hospitality (DRH) and Voyager Therapeutics (VYGR). Company Calendar Last Earnings5/06/2025Today6/22/2025Next Earnings (Estimated)8/05/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Medical Services Sub-IndustryHealthcare Current SymbolNYSE:AGL CIK1831097 Webagilonhealth.com Phone562-256-3800FaxN/AEmployees1,076Year FoundedN/APrice Target and Rating Average Stock Price Target$4.79 High Stock Price Target$9.00 Low Stock Price Target$3.00 Potential Upside/Downside+126.3%Consensus RatingHold Rating Score (0-4)2.17 Research Coverage18 Analysts Profitability EPS (Most Recent Fiscal Year)($0.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$260.15 million Net Margins-4.04% Pretax Margin-4.24% Return on Equity-45.47% Return on Assets-12.76% Debt Debt-to-Equity RatioN/A Current Ratio1.20 Quick Ratio1.20 Sales & Book Value Annual Sales$6.06 billion Price / Sales0.14 Cash FlowN/A Price / Cash FlowN/A Book Value$1.14 per share Price / Book1.86Miscellaneous Outstanding Shares413,950,000Free Float399,174,000Market Cap$875.50 million OptionableNot Optionable Beta0.14 20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free Report This page (NYSE:AGL) was last updated on 6/22/2025 by MarketBeat.com Staff From Our PartnersWar Tensions Are Making Gold Rise to Record HighsIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agilon Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Agilon Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.